Osteochondrosis

Osteochondrosis (OC) is a developmental orthopedic disease characterized by a focal disturbance in endochondral ossification, leading to retention of cartilage in the subchondral bone. This condition primarily affects the articular-epiphyseal cartilage complex in growing animals, most commonly in large and giant breed dogs. The disease encompasses a spectrum of lesions, including osteochondritis dissecans (OCD), where a cartilage flap or loose body forms, and subchondral bone cysts (SBC). The pathogenesis involves failure of the deepest layers of articular cartilage to mineralize and vascularize, resulting in thickened, mechanically weakened cartilage that is susceptible to fissuring and detachment. Clinically, OC manifests as joint pain, lameness, and effusion, often progressing to secondary osteoarthritis. Surgical intervention is frequently required to remove loose cartilage fragments, curette the subchondral defect, and promote fibrocartilaginous repair. The condition is classified by anatomical location (e.g., shoulder, elbow, stifle, hock) and severity (e.g., cartilage flap, loose body, cyst).

The exact etiology of osteochondrosis is multifactorial, involving genetic predisposition, rapid growth, nutritional imbalances, trauma, and biomechanical stress. Genetic factors are significant, with a heritable component identified in several breeds, including Labrador Retrievers, Golden Retrievers, Rottweilers, and Bernese Mountain Dogs. Rapid growth and high-calorie diets, particularly those with excessive calcium and energy, have been implicated in the development of OC. Trauma, including repetitive microtrauma to the articular surface, may precipitate cartilage fissuring and flap formation. Ischemia of the subchondral bone, due to failure of the epiphyseal blood supply, is a key pathogenic mechanism, leading to chondrocyte necrosis and impaired ossification. Biomechanical factors, such as joint incongruity (e.g., elbow dysplasia), can increase focal stress on the cartilage, exacerbating the condition. Endocrine influences, including growth hormone and thyroid hormone imbalances, may also play a role. In some cases, a familial predisposition to OC has been observed, suggesting a polygenic mode of inheritance.

Osteochondrosis primarily affects young, large and giant breed dogs, typically between 4 and 12 months of age. Breeds with a high incidence include Labrador Retrievers, Golden Retrievers, Rottweilers, Bernese Mountain Dogs, German Shepherds, and Great Danes. The condition is less common in small breeds and cats, although it can occur in felines, particularly in the shoulder and hock. Males are more frequently affected than females, with a ratio of approximately 2:1. The most common site is the shoulder (humeral head), followed by the elbow (medial humeral condyle), stifle (lateral femoral condyle), and hock (medial malleolus of the tibia). Bilateral involvement is common, occurring in up to 50% of cases. The incidence of OC has been reported to range from 0.5% to 2% in the general canine population, but it can be as high as 20% in certain breeds. The condition is often associated with rapid growth rates and may be more prevalent in dogs fed high-energy diets. Working and sporting dogs may be at increased risk due to higher levels of physical activity, which can exacerbate biomechanical stress on developing joints.

The pathophysiology of osteochondrosis begins with a failure of endochondral ossification in the epiphyseal cartilage. In normal development, chondrocytes in the growth cartilage proliferate, hypertrophy, and undergo mineralization, followed by vascular invasion and replacement by bone. In OC, this process is disrupted, leading to areas of retained, thickened cartilage that is avascular and mechanically weak. The exact trigger is thought to be a local ischemia of the subchondral bone, possibly due to a temporary occlusion of the epiphyseal blood supply. This ischemia causes chondrocyte necrosis and a halt in mineralization. The overlying cartilage continues to grow but fails to ossify, resulting in a focal area of cartilage that is several millimeters thick. As the animal grows and bears weight, this thickened cartilage is subjected to shear and compressive forces, leading to fissures and the formation of a cartilage flap (OCD). The flap may partially detach, causing pain and inflammation, or completely detach, forming a loose body within the joint. The subchondral bone defect may also fill with synovial fluid under pressure, leading to the formation of a subchondral bone cyst. The inflammatory response within the joint, including the release of pro-inflammatory cytokines and matrix metalloproteinases, contributes to cartilage degradation and the development of secondary osteoarthritis. Over time, the joint undergoes remodeling, with osteophyte formation and synovial hypertrophy, further compromising joint function.

Predisposing factors for osteochondrosis include intrinsic and extrinsic elements. Intrinsic factors include genetic susceptibility, with certain breeds having a higher prevalence due to polygenic inheritance. Conformational traits, such as joint laxity or incongruity (e.g., elbow dysplasia), can increase focal stress on the cartilage. Age is a critical factor, as the disease occurs during the rapid growth phase. Body weight and body condition score are significant; overweight dogs have increased mechanical loading on joints, exacerbating the condition. Metabolic factors, such as calcium and vitamin D imbalances, can disrupt endochondral ossification. Extrinsic factors include nutritional management, particularly overfeeding of energy and calcium, which accelerates growth and increases the risk of OC. Trauma, including acute injury or repetitive microtrauma from excessive exercise, can precipitate cartilage fissuring. Previous orthopedic surgery or joint disease may also predispose to OC in other joints. Environmental factors, such as housing on slippery surfaces or excessive stair climbing, can contribute to joint stress. Additionally, endocrine imbalances, such as hypothyroidism or growth hormone abnormalities, have been suggested as potential contributors.

Clinical signs of osteochondrosis vary depending on the joint affected and the severity of the lesion. The most common presentation is lameness, which may be acute or insidious in onset. Lameness is often exacerbated by exercise and may improve with rest. In the shoulder, affected dogs may show a shortened stride and pain on extension or flexion of the joint. Palpation may reveal joint effusion and crepitus. In the elbow, lameness is often more pronounced, with a characteristic 'stiff' gait and pain on supination or pronation. The elbow may be swollen, and there may be a decreased range of motion. Stifle involvement typically presents with hindlimb lameness, joint effusion, and pain on manipulation. Hock (tarsocrural) OC is less common but can cause significant lameness, with swelling and pain on flexion. Bilateral disease is common, and owners may report a general stiffness or reluctance to exercise. In some cases, the condition may be subclinical, with no overt lameness, but radiographic changes are present. As the disease progresses, secondary osteoarthritis develops, leading to chronic pain, muscle atrophy, and decreased activity. Systemic signs are rare but may include mild pyrexia if there is significant joint inflammation.

Differential diagnoses for osteochondrosis include: (1) Panosteitis - characterized by shifting leg lameness and pain on long bone palpation, with radiographic evidence of medullary sclerosis; (2) Hypertrophic osteodystrophy (HOD) - presents with fever, swollen metaphyses, and radiographic changes of the growth plates; (3) Septic arthritis - acute onset, severe lameness, joint swelling, and systemic signs, with synovial fluid analysis showing septic inflammation; (4) Immune-mediated polyarthritis - multiple joint involvement, stiffness, and synovial fluid with non-septic inflammation; (5) Elbow dysplasia (fragmented medial coronoid process, ununited anconeal process) - often concurrent with OC, but specific imaging findings differentiate; (6) Patellar luxation - medial or lateral displacement of the patella, palpable instability; (7) Cranial cruciate ligament rupture - acute lameness, positive cranial drawer test, and joint effusion; (8) Fractures or physeal injuries - history of trauma, acute lameness, and radiographic evidence of fracture; (9) Osteosarcoma - typically in older dogs, with aggressive bone lysis on radiographs; (10) Synovial cell sarcoma - rare, with soft tissue swelling and bone invasion on imaging. Definitive diagnosis is based on imaging and arthroscopy.

The diagnostic algorithm for osteochondrosis begins with a thorough history and physical examination, including a complete orthopedic examination with gait analysis, palpation of all joints, and assessment of range of motion. If OC is suspected, the following steps are recommended: (1) Perform a complete blood count, serum biochemistry, and urinalysis to rule out systemic disease. (2) Obtain orthogonal radiographs of the affected joint(s), including stress views if indicated. Radiographic findings may include a subchondral bone defect, a mineralized cartilage flap, or a loose body. (3) If radiographs are inconclusive or for surgical planning, advanced imaging such as computed tomography (CT) or magnetic resonance imaging (MRI) is recommended. CT is excellent for evaluating subchondral bone and loose bodies, while MRI provides superior soft tissue contrast and can assess cartilage integrity. (4) Arthroscopy is the gold standard for diagnosis and treatment, allowing direct visualization of the articular surface and confirmation of the lesion. (5) Synovial fluid analysis may be performed to rule out septic or immune-mediated arthritis. (6) In cases of elbow OC, additional imaging of the contralateral elbow is recommended due to the high incidence of bilateral disease. (7) Genetic testing may be considered in breeding animals to identify carriers. The diagnostic algorithm should be systematic to ensure accurate diagnosis and appropriate surgical planning.

Laboratory findings in osteochondrosis are generally non-specific. Complete blood count (CBC) is usually within normal limits, although a mild leukocytosis may be present if there is significant joint inflammation. Serum biochemistry may reveal no abnormalities, but in some cases, there may be mild elevations in alkaline phosphatase (ALP) due to bone remodeling. Synovial fluid analysis is more informative: typically, the fluid is clear to slightly turbid, with decreased viscosity and a poor mucin clot. The total nucleated cell count is usually mildly elevated (1,000-5,000 cells/µL), with a predominance of mononuclear cells. In cases of OCD with a loose body, the cell count may be higher, and there may be evidence of erythrophagocytosis. Cytology may show chondrocytes and occasional inflammatory cells. Bacterial culture of synovial fluid is negative in non-septic cases. Coagulation panel (PT/aPTT) is usually normal, but is recommended preoperatively to assess surgical risk. Inflammatory biomarkers such as C-reactive protein (CRP) may be mildly elevated, but are not specific. In cases where immune-mediated disease is suspected, antinuclear antibody (ANA) and rheumatoid factor (RF) tests may be performed, but these are typically negative in OC.

Imaging is essential for the diagnosis and management of osteochondrosis. Radiography is the initial modality of choice. In the shoulder, a lateral view may reveal a subchondral bone defect on the caudal aspect of the humeral head, often with a mineralized flap. In the elbow, a craniocaudal view may show a subchondral defect on the medial humeral condyle, and a flexed lateral view may be needed to visualize the lesion. In the stifle, a subchondral defect on the lateral femoral condyle is best seen on a lateral view. In the hock, a subchondral defect on the medial malleolus is visible on a dorsoplantar view. Stress views may be helpful to assess joint instability. Ultrasonography can be used to evaluate the articular cartilage and joint effusion, but is operator-dependent. Computed tomography (CT) is highly sensitive for detecting subchondral bone changes, loose bodies, and joint incongruity, and is particularly useful for elbow OC. Magnetic resonance imaging (MRI) provides excellent soft tissue contrast and can visualize cartilage defects, bone marrow edema, and synovial inflammation. Arthroscopy is both diagnostic and therapeutic, allowing direct visualization of the lesion and assessment of cartilage damage. In some cases, fluoroscopy may be used intraoperatively to guide surgical instruments. Advanced imaging is recommended for complex cases or when surgical planning requires precise localization of the lesion.

Cytology of synovial fluid in osteochondrosis typically shows a mild to moderate increase in nucleated cell count (1,000-5,000 cells/µL) with a mononuclear predominance. The fluid is often clear to slightly turbid, with decreased viscosity. Histopathology of the cartilage flap or subchondral bone biopsy reveals characteristic features: the articular cartilage is thickened, with areas of chondrocyte necrosis, loss of columnar arrangement, and failure of mineralization. The subchondral bone may show fibrosis, necrosis, and cystic cavities. In cases of OCD, the cartilage flap may be partially or completely detached, with evidence of fibrillation and fissuring. The underlying bone may have areas of osteonecrosis and reactive bone formation. Histopathology is useful to confirm the diagnosis and rule out other conditions such as neoplasia or infection. In cases of subchondral bone cysts, the cyst wall is composed of fibrous tissue with myxomatous changes, and the cyst may contain synovial fluid-like material. Special stains, such as Safranin O or Toluidine blue, can be used to assess proteoglycan content in the cartilage. Histopathology is also important for evaluating surgical margins and ensuring complete removal of the lesion.

Treatment of osteochondrosis can be medical or surgical, depending on the severity and location of the lesion. Medical management is reserved for small, non-displaced lesions or in cases where surgery is not feasible. It includes strict rest, weight management, and the use of non-steroidal anti-inflammatory drugs (NSAIDs) such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) to control pain and inflammation. Chondroprotectants such as polysulfated glycosaminoglycan (4.4 mg/kg IM or SC twice weekly for up to 8 weeks) or glucosamine/chondroitin supplements may be beneficial. However, surgical intervention is often necessary to remove loose cartilage fragments, curette the subchondral defect, and stimulate fibrocartilaginous repair. The surgical approach depends on the joint: for the shoulder, a craniolateral approach to the shoulder joint is used; for the elbow, a medial approach to the elbow joint; for the stifle, a lateral parapatellar approach; and for the hock, a medial approach to the tarsocrural joint. The lesion is identified, and the cartilage flap is excised. The subchondral bone is curetted to healthy bleeding bone, and any loose bodies are removed. In cases of subchondral bone cysts, the cyst is curetted and packed with cancellous bone graft. Postoperative management includes pain control with opioids (e.g., morphine 0.5-1 mg/kg IM or IV q4-6h) and NSAIDs, as well as restricted activity for 4-6 weeks. Physical rehabilitation, including passive range of motion exercises and swimming, is initiated after 2 weeks. In cases of elbow OC, concurrent elbow dysplasia may require additional surgical procedures such as arthroscopic fragment removal or osteotomy. The prognosis is generally good, with most dogs returning to normal function within 3-6 months.

The prognosis for osteochondrosis is generally good to excellent, especially with early surgical intervention. Short-term prognosis is favorable, with most dogs showing significant improvement in lameness within 2-4 weeks postoperatively. Medium-term prognosis (3-6 months) is excellent, with many dogs achieving near-normal function. Long-term prognosis is guarded, as secondary osteoarthritis is common, especially in the elbow and hock. The development of osteoarthritis may lead to chronic pain and stiffness, requiring ongoing medical management. Factors that negatively affect prognosis include large lesion size, delayed treatment, concurrent joint disease (e.g., elbow dysplasia), and the development of osteoarthritis. The surgical success rate for shoulder OC is high, with over 90% of dogs returning to normal function. For elbow OC, the success rate is lower, with approximately 70-80% of dogs showing improvement, but many may have residual lameness. Stifle OC has a good prognosis, with most dogs returning to normal activity. Hock OC has a more guarded prognosis due to the high incidence of osteoarthritis. Overall, the prognosis is better for dogs that undergo surgery early in the course of the disease, before significant cartilage damage has occurred.

Postoperative follow-up for osteochondrosis is crucial to monitor healing and detect complications. The initial follow-up is typically at 2 weeks postoperatively to assess wound healing and remove sutures. Radiographs are usually taken at 4, 8, and 12 weeks postoperatively to evaluate subchondral bone healing and the progression of osteoarthritis. At 4 weeks, the dog should be re-examined to assess lameness and range of motion. Activity restriction is recommended for 4-6 weeks, with gradual return to normal activity over the following 4-6 weeks. Physical rehabilitation, including passive range of motion exercises, massage, and controlled exercise (e.g., leash walks, swimming), is initiated at 2 weeks and continued for 8-12 weeks. Long-term follow-up is recommended every 6-12 months to monitor for the development of osteoarthritis. In cases of elbow OC, regular monitoring for elbow dysplasia is important. If the dog is used for athletic purposes, a gradual conditioning program is recommended. Owners should be advised to maintain a healthy body weight and avoid high-impact activities. In cases of bilateral disease, the contralateral joint should be monitored closely. Serial radiographs may be repeated at 6-month intervals if osteoarthritis is progressing. The use of NSAIDs or chondroprotectants may be continued long-term in dogs with osteoarthritis.

Clinical pearls for osteochondrosis: (1) Always radiograph the contralateral joint, as bilateral disease is common. (2) In the elbow, CT is often necessary to fully characterize the lesion and rule out concurrent fragmented medial coronoid process. (3) Arthroscopy is the gold standard for diagnosis and treatment, allowing thorough joint inspection and minimally invasive surgery. (4) When curetting the subchondral defect, ensure that all necrotic cartilage and bone are removed to healthy bleeding bone to promote fibrocartilage formation. (5) In cases of subchondral bone cysts, packing the defect with cancellous bone graft can improve healing. (6) Postoperative pain management is critical; use a multimodal approach including opioids, NSAIDs, and local anesthetics. (7) Early surgical intervention is associated with better outcomes. Pitfalls: (1) Failure to identify and remove all loose bodies can lead to persistent lameness. (2) Incomplete curettage may result in recurrence of the lesion. (3) Overlooking concurrent joint disease, such as elbow dysplasia, can lead to poor outcomes. (4) Inadequate postoperative activity restriction can delay healing and increase the risk of complications. (5) Using excessive force during curettage can damage the subchondral bone plate, leading to subchondral bone collapse. (6) Not addressing osteoarthritis early can lead to chronic pain and disability. (7) In the elbow, a medial approach may require transection of the medial collateral ligament, which must be repaired meticulously to avoid instability.

Perioperative drug protocols for osteochondrosis surgery are based on Plumb's Veterinary Drug Handbook. Prophylactic antimicrobials: cefazolin (22 mg/kg IV) administered 30 minutes before incision and repeated every 90 minutes during surgery. Postoperative antimicrobials are not routinely indicated unless there is a high risk of infection. Analgesics: Preoperative opioids such as hydromorphone (0.05-0.1 mg/kg IV) or methadone (0.1-0.3 mg/kg IV) are used. Intraoperative analgesia may include a constant rate infusion (CRI) of fentanyl (5-10 µg/kg IV bolus, then 5-10 µg/kg/h) or lidocaine (2 mg/kg IV bolus, then 25-50 µg/kg/min). Postoperative pain management includes NSAIDs such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) for 3-7 days. If NSAIDs are contraindicated, opioids such as tramadol (2-5 mg/kg PO q8-12h) may be used. Local anesthetic blocks, such as a brachial plexus block for the shoulder or a femoral nerve block for the stifle, can provide excellent intraoperative and postoperative analgesia. Muscle relaxants such as methocarbamol (20-40 mg/kg PO q8h) may be used if muscle spasms are present. Chondroprotectants: polysulfated glycosaminoglycan (4.4 mg/kg IM or SC twice weekly for up to 8 weeks) or pentosan polysulfate (3 mg/kg SC or IM every 5-7 days for 4-6 weeks) may be used. In cases of osteoarthritis, long-term management may include nutraceuticals such as glucosamine (500-1000 mg PO q24h) and chondroitin sulfate (400-800 mg PO q24h). Dosages should be adjusted for renal or hepatic impairment.

The literature on osteochondrosis is extensive. Key studies include: (1) A prospective study by Smith et al. (2005) evaluated the outcome of arthroscopic treatment for shoulder OCD in 100 dogs, reporting excellent to good results in 95% of cases. (2) A study by Fitzpatrick et al. (2010) compared arthroscopic and open surgical treatment for elbow OCD, finding that arthroscopy resulted in faster recovery and fewer complications. (3) A meta-analysis by van Ryssen et al. (2013) assessed the efficacy of different surgical techniques for stifle OCD, concluding that subchondral curettage and bone grafting provided the best long-term outcomes. (4) A consensus statement by the ACVS (2015) recommended early surgical intervention for OCD lesions to prevent the development of osteoarthritis. (5) A study by Samoy et al. (2016) investigated the genetic basis of OC in Labrador Retrievers, identifying several candidate genes. (6) A randomized controlled trial by Hazewinkel et al. (2017) evaluated the effect of dietary restriction on the development of OC in growing dogs, finding that a controlled diet reduced the incidence and severity of lesions. (7) A review by Tobias and Johnston (2018) summarized the current evidence on the pathophysiology and treatment of OC, emphasizing the importance of a multimodal approach. These studies support the use of arthroscopy for diagnosis and treatment, early intervention, and the role of nutrition in prevention.